NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-CA-20-073 from the NIH Guide for Grants and Contracts
Notice NOT-OD-20-127 from the NIH Guide for Grants and Contracts
Notice NOT-HD-20-023 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-HD-21-008 from the NIH Guide for Grants and Contracts. The NIH is coordinating efforts for establishing a developmental Genotype-Tissue Expression (dGTEx) project, to catalog and analyze transcriptional profiles from a wide variety of tissues obtained from neonates, children, and adolescents in a post-mortem setting. The purpose of this funding opportunity is for support of a Biospecimen Procurement Center (BPC) to enroll suitable pediatric donors and provide high quality tissue samples for analyses to the Laboratory, Data Analysis, and Coordinating Center (LDACC). The BPC will work closely with the LDACC to optimize tissue collection, preservation and transfer of specimens.
Notice NOT-EY-20-010 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-HG-20-039 from the NIH Guide for Grants and Contracts. The National Human Genome Research Institute (NHGRI) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development are coordinating efforts for establishing a Developmental Genotype-Tissue Expression (dGTEx) project, to catalog and analyze transcriptional profiles from a wide variety of tissues obtained from neonates, children, and adolescents in a post-mortem setting. The purpose of this FOA is to solicit applications to develop and implement a Laboratory, Data Analysis, and Coordinating Center (LDACC) for the Developmental Genotype-Tissue Expression (dGTEx) Project. The LDACC will perform 2 major functions: a molecular laboratory, and a data analysis and coordinating center. As a molecular laboratory, the LDACC will work with the Biospecimen Procurement Center (BPC) funded by NICHD to process tissue samples for sequencing and biobanking. Responsibilities as a data analysis and coordinating center include ensuring close coordination with the BPC, monitoring study progress and laboratory performance, performing basic analysis of data for gene expression analyses, and harmonizing and submitting datasets to be deposited in repositories such as the AnVIL ((Analysis, Visualization, and Informatics Lab-space) https://anvilproject.org/) or the GTEx portal (https://gtexportal.org/home/).
Notice NOT-AI-20-054 from the NIH Guide for Grants and Contracts
Notice NOT-AG-20-037 from the NIH Guide for Grants and Contracts
Notice NOT-OD-20-130 from the NIH Guide for Grants and Contracts
Notice NOT-OD-20-131 from the NIH Guide for Grants and Contracts
Notice NOT-OD-20-126 from the NIH Guide for Grants and Contracts
Notice NOT-RM-20-019 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-LM-20-001 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites cooperative agreement (UG4) applications for Regional Medical Libraries (RMLs) as the central component of the Network of the National Library of Medicine (NNLM). The NNLM consists of 7 regional medical libraries and thousands of member organizations located throughout the US. The mission of the NNLM is to provide U.S. researchers, health professionals, public health workforce, educators, and the public with equal access to biomedical and health information resources and data. The RMLs carry out regional and national programs in support of the mission. This includes training, funding, and engagement opportunities for member libraries and other organizations to carry out regional and national programs. Regionally, RMLs assess and interpret the needs of current and potential audiences to expand the reach and impact of the National Library of Medicine (NLM). As a group, the RMLs ensure continuity for essential programs of the NNLM, and cooperatively design, implement, and evaluate innovative approaches to serving the biomedical and health information needs of researchers, health professionals, public health workforce, educators, and the public in communities across the U.S., including persons who experience health disparities and populations underrepresented in biomedical research.
Notice NOT-OD-20-125 from the NIH Guide for Grants and Contracts
Notice NOT-DK-20-034 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-20-237 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications to implement and evaluate community interventions testing 1) the impacts of mitigation strategies to prevent COVID-19 transmission in NIH-designated health disparity populations and other vulnerable groups; and 2) already implemented, new, or adapted interventions to address the adverse psychosocial, behavioral, and socioeconomic consequences of the pandemic on the health of these groups.
Notice NOT-GM-20-037 from the NIH Guide for Grants and Contracts
Notice NOT-MH-20-062 from the NIH Guide for Grants and Contracts
Notice NOT-RM-20-020 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-20-233 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications that propose transformative engineering solutions to technical challenges associated with new development, substantial optimization of existing technologies and clinical translation of intraoral biodevices. Proposed technologies are expected to advance development of oral biodevices for clinical use, including but not limited to: precision medicine-based detection, diagnosis and treatment of oral and overall health conditions, and measurement of patient functional status and clinical outcome assessment. Areas of interest in this FOA include engineering approaches that allow integration of electronic, physical, and biological systems into functional biodevices that are safe and effective for detection, diagnosis and treatment of oral and systemic disease. Products of this research will be functional biodevices and integrated approaches thoroughly characterized to demonstrate preclinical safety and effective performance in support of specific intended clinical applications. To streamline the development of oral biodevices that advance precision medicine-based approaches in clinical practice, this FOA encourages interdisciplinary collaborations across engineering, multifunctional sensors, pharmacology, chemistry, medicine, and dentistry, as well as between academia and industry.